Risk Of Developing Liver Cancer After HCV Treatment

Monday, October 4, 2010

PegIntron/Pegasys both comparable except in price



Consumer Reports recommendations regarding PegIntron and Pegasys used for treating Hepatitis C.


Today the magazine reported; PegIntron and Pegasys were both found to be comparable when eliminating the HCV virus. However the article added there was a pretty big difference between the drugs when it came to cost . Who knew?


"PegIntron could save you $72 to $820 per month over Pegasys, depending on the formulation you need. Most people will be treated for at least 24 weeks (about 5 and a half months), and possibly for 48 weeks (a little over 11 months). So the average savings of PegIntron could be significant, ranging from $403 to $4,592 over 24 weeks to $806 to $9,184 over 48 weeks. Each pegylated interferon is only approved to be used in combination with a specific branded ribavirin (Copegus with Pegasys and Rebetol with PegIntron).

However, generic ribavirin tablets may be your best bet because they are significantly less expensive. A month's supply of generic ribavirin will save you $600 to $1,050 per month over Rebetol and $1,320 to $2,310 per month over Copegus, depending on dose. "



No comments:

Post a Comment